Us Drugmakers
-
{
- All
- News
- Videos
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
Cheap Generic Ozempic To Hit India: Patent Exit Sparks Weight-Loss Drug Boom
Swati Pradhan sees about 12 obesity patients a day at her clinic in southern Mumbai. She expects this number to at least double from this month as Indian drug makers prepare to launch off-patent versions of Novo Nordisk A/S's blockbuster weight.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
Trump Announces Pfizer Deal Offering Discounts On Medicines Via 'TrumpRx' Website
Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
No More Covid Boosters For Healthy Children, Adult Americans Without New Trials
US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.
-
"Everybody Should Pay Same": Inside Trump's Order To Slash Drug Prices In US
US President Donald Trump has signed an executive order directing pharmaceutical companies to slash drug prices so they match those abroad.
-
Audi, Cheerios Maker General Mills Pause Advertising on Twitter After Elon Musk Takeover
Luxury carmaker Audi and General Mills, the maker of Cheerios, said on Thursday that they had paused advertising on the microblogging platform, nearly a week after Elon Musk's takeover was completed. Meanwhile, the Wall Street Journal reported on Thursday that Oreo maker Mondelez International and US drugmaker Pfizer also temporarily halted adverti...
-
Anti-Covid Pill "Active" Against Omicron: Merck
Merck's anti-Covid pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
-
Denmark First In European Union To Authorise Merck Covid Pill
Denmark on Thursday recommended US drugmaker Merck's anti-Covid treatment molnupiravir for at-risk patients with symptoms, becoming the first EU country to do so.
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
US Court Overturns Historic Opioid Ruling Against Drugmaker Johnson & Johnson
The Oklahoma State Supreme Court on Tuesday overturned a historic decision to fine US pharmaceutical giant Johnson & Johnson $465 million for its role in the opioid crisis.
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
Cheap Generic Ozempic To Hit India: Patent Exit Sparks Weight-Loss Drug Boom
Swati Pradhan sees about 12 obesity patients a day at her clinic in southern Mumbai. She expects this number to at least double from this month as Indian drug makers prepare to launch off-patent versions of Novo Nordisk A/S's blockbuster weight.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
Trump Announces Pfizer Deal Offering Discounts On Medicines Via 'TrumpRx' Website
Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
No More Covid Boosters For Healthy Children, Adult Americans Without New Trials
US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.
-
"Everybody Should Pay Same": Inside Trump's Order To Slash Drug Prices In US
US President Donald Trump has signed an executive order directing pharmaceutical companies to slash drug prices so they match those abroad.
-
Audi, Cheerios Maker General Mills Pause Advertising on Twitter After Elon Musk Takeover
Luxury carmaker Audi and General Mills, the maker of Cheerios, said on Thursday that they had paused advertising on the microblogging platform, nearly a week after Elon Musk's takeover was completed. Meanwhile, the Wall Street Journal reported on Thursday that Oreo maker Mondelez International and US drugmaker Pfizer also temporarily halted adverti...
-
Anti-Covid Pill "Active" Against Omicron: Merck
Merck's anti-Covid pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
-
Denmark First In European Union To Authorise Merck Covid Pill
Denmark on Thursday recommended US drugmaker Merck's anti-Covid treatment molnupiravir for at-risk patients with symptoms, becoming the first EU country to do so.
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
US Court Overturns Historic Opioid Ruling Against Drugmaker Johnson & Johnson
The Oklahoma State Supreme Court on Tuesday overturned a historic decision to fine US pharmaceutical giant Johnson & Johnson $465 million for its role in the opioid crisis.
